Close Menu
    What's Hot

    Fujifilm UK Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    November 11, 2026

    Clariant Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

    November 11, 2026

    Editor’s Letter – Volume 2, Issue 11, November 2026

    November 11, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Symetra and TIAA Partner To Launch Mariner Re

      October 27, 2026

      Chariot Re Announces Fourth Reinsurance Transaction, First Covering Japanese Liabilities

      October 15, 2026

      Pacific Life Re Executes First Asset-Intensive Reinsurance Transaction in Hong Kong

      September 9, 2026

      Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

      September 9, 2026

      Q&A: Alexandr Dudarev, CEO, Inshurik

      October 28, 2026

      Is Dementia the Next Big Longevity Event?

      October 15, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Fujifilm UK Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      November 11, 2026

      Clariant Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

      November 11, 2026

      Sponsor Demand Intact as US Pension Risk Transfer Market Prepares for Busy Year-End

      November 11, 2026

      Delcam Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      November 5, 2026

      Record Low Mortality Rates So Far in 2026 in England and Wales, Says CMI

      October 12, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Global Equity Release Market Participants Remain Bullish Despite Macro Headwinds

      November 11, 2026
      Litigation

      Litigation Update: Estate of Long v. Wells Fargo Bank, N.A.

      November 11, 2026

      Life Insurance Settlement Association Announces New Chair, Composition of Board for 2027

      November 11, 2026

      UK Equity Release Activity Nudges Higher in Third Quarter

      October 28, 2026

      Fujifilm UK Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      November 11, 2026

      Clariant Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

      November 11, 2026

      Editor’s Letter – Volume 2, Issue 11, November 2026

      November 11, 2026

      Global Equity Release Market Participants Remain Bullish Despite Macro Headwinds

      November 11, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 11, November 2026

      November 11, 2026
      Life Risk News Editors Letter

      Editor’s Letter – Volume 2, Issue 10, October 2026

      October 15, 2026

      Editor’s Letter – Volume 2, Issue 9, September 2026

      September 9, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Mark Sharkey, BPA Origination Lead, Royal London

    Longevity and Mortality Risk Transfer February 12, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    The pension risk transfer market in the UK delivered yet another solid year in 2024 with consultants WTW forecasting that, when all is said and done, £48-50bn of deals will have been completed, which could mean a record. Greg Winterton spoke to Mark Sharkey, BPA Origination Lead at Royal London, to get his views on the state of the market and its outlook for 2025. 

    GW: Mark, last year was yet another high-activity year in the UK’s bulk purchase annuity market. Just how long can this go on for? 

    MS: There is every reason to expect the bulk annuity market will be as vibrant in 2025 as it has been in recent years. There are lots of pension schemes now ready to transact or preparing to in the months and years ahead. We also now have more insurers in the market than ever before. So, there is plenty of supply and plenty of demand. It’s worth remembering that around £1trn of defined benefit pension liabilities remain uninsured in the UK, so the potential demand is significant. 

    We expect to see £40-50bn of business across the market again this year, but there could be fewer multi-billion transactions with more sub-£500 million transactions making up the difference. 

    GW: Royal London itself entered the market officially in 2024, writing deals mainly in the smaller end of the market so far. What are some of your thoughts on what should be top of mind for smaller scheme trustees as they approach the BPA market for a quotation? 

    MS: The market is very busy right now, with over 200 transactions being completed each year for pension schemes within our target premium range of up to £500m. However, we don’t envisage a scenario where a well-prepared smaller pension scheme is unable to gain traction with an insurer, and that’s backed up by what we’re observing in the market. 

    Most insurers in the market run similar triaging processes when deciding which pension schemes to provide a quote to. Generally, insurers will prioritise opportunities with good quality data, a clear presentation of scheme benefits and good governance and brokering processes. 

    What we’d also recommend to trustees is that they can demonstrate they have taken the time up front to understand the offerings from insurers and how they differ. This encourages insurers to reciprocate and lean in to work with trustees that are well aligned to their proposition. 

    GW: Given the excellent funding status of many schemes, there has been a growing amount of talk around whether to de-risk at all. What’s your message here? 

    MS: Ultimately the decision on whether to de-risk is one for the pension scheme trustees to make, as they carry out their fiduciary duties and ensure the long-term security of members’ benefits. There will be instances when a bulk annuity transaction isn’t the optimum outcome for a pension scheme and trustee board. However, many of the trustees we speak to are keen to lock in the funding gains that have emerged over the last few years. Many trustees remember the surpluses of the 1990s and how quickly they disappeared. 

    Most trustees I speak to are from pension schemes of up to a few hundred million pounds. The cost of running these pension schemes on can be prohibitively high and often the corporate sponsors just simply don’t want to be investing so much of their time managing these pension schemes, they’d much rather be focused on growing their businesses. 

    GW: How much are smaller schemes paying attention to the investment strategy of the insurers that they might eventually transact with? Are there any misconceptions here, or lack of understanding on behalf of the scheme trustees? 

    MS: The investment strategies adopted by bulk annuity providers need to balance the returns required to offer attractive pricing with the regulatory regime they must comply with. This can often lead to differences between the assets held by a pension scheme compared with the typical insurer, even though both seek to match defined benefit cashflows. Insurers might typically weight their portfolio more towards credit and less towards gilts compared to the typical pension scheme, whilst certain illiquid assets held by pension schemes are not permissible under Solvency UK.  

    However, I think investment consultants have really upped their game in recent years, in terms of getting pension schemes of all sizes ‘transaction ready’. Many trustees we speak to have already undergone a process of aligning their portfolio to something that looks more like an insurer strategy, but good insurance partners will still do their best to retain an element of flexibility when working with pension schemes on a transaction.  

    GW: Lastly, Mark, what is yours and Royal London’s outlook for activity in the space this year? When 2025 is said and done, do you think a new record will be set in terms of aggregate deal value, or will there be a plateauing? Or a contraction? 

    MS: I think aggregate volumes have reached a fairly steady level, so would expect something similar to previous years when the industry gets the calculator out and tots up the final scores. 

    Whether 2025 represents a new record, a contraction or a plateau, I’m sure all the headlines will reference the total amount of liability that has transferred to the bulk annuity market. But ultimately, the main focus should be on the number of members that have reached buy-in and achieved greater benefit security as a result.  

    Mark Sharkey is BPA Origination Lead at Royal London 

    2025 - February Longevity Risk Pension Risk Transfer Q&A Volume 4 Issue 2 - February 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Fujifilm UK Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    November 11, 2026By LMI Newsdesk

    Clariant Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

    November 11, 2026By LMI Newsdesk

    Sponsor Demand Intact as US Pension Risk Transfer Market Prepares for Busy Year-End

    November 11, 2026By Greg Winterton

    Delcam Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    November 5, 2026By LMI Newsdesk
    Latest Issue

    Global Equity Release Market Participants Remain Bullish Despite Macro Headwinds

    November 11, 2026
    Litigation

    Litigation Update: Estate of Long v. Wells Fargo Bank, N.A.

    November 11, 2026

    Sponsor Demand Intact as US Pension Risk Transfer Market Prepares for Busy Year-End

    November 11, 2026

    New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

    October 28, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.